Navigation Links
The Breast Cancer Therapeutics Market in Australia
Date:8/5/2009

SYDNEY, Aug. 5 /PRNewswire/ -- Rising public awareness of breast cancer and available treatments have increased revenues in the breast cancer therapeutics market in Australia. As the most common cancer diagnosed in Australia's female population, the total number of breast cancer patients in the country was 164,814 in 2008. This figure is estimated to reach 304,511 patients by 2013. Globally, breast cancer is second to lung cancer as the cause of death among women.

(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO)

Initiatives such as the BreastScreen Australia program, which provides free mammography services to aid in the early detection of breast cancer, have resulted in oncologists seeing more early stage disease. This, combined with aggressive and targeted therapy has, in turn, resulted in a reduction in the number of locally-advanced and metastatic breast cancer patients in the country.

The use of molecular targeted therapies as effective forms of cancer therapy is becoming more prevalent. These therapies are specifically designed to target cancer cells, while minimizing the adverse effects on normal cells when compared to cytotoxic chemotherapeutic drugs. New offerings must constitute therapies that will improve quality of life and survival rates if they are to thrive in this highly competitive market.

"Biopharmaceutical companies are placing more emphasis on developing targeted breast cancer therapies that offer patients not only increased efficacy, but reduced side effects as well," explains Carole Gaffud, Frost & Sullivan Research Analyst. "There are several new targeted therapies and chemotherapy drugs under development, including Epotheliones and Vascular Endothelial Growth Factor Receptor (VEGFR) inhibitors."

However
'/>"/>

SOURCE Frost & Sullivan
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ImmunoVaccine Technologies Licenses Immunotopes Breast, Ovarian and Prostate Cancer Antigens
2. Significant Milestone Marks the Beginning of FDA-Authorized Breast Cancer Trial
3. Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer
4. New MRI technique could mean fewer breast biopsies in high-risk women
5. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast Cancer
6. Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer
7. DNA Genotek Partners with Roswell Park Cancer Institute to Accelerate Breast Cancer Research
8. Peregrine Pharmaceuticals Presents Promising Data From Its Phase II Bavituximab Breast Cancer Trial at 2009 ASCO Annual Meeting
9. Agendia to Present Multiple Predictive and Prognostic Studies on Breast and Colorectal Cancers at ASCO Annual Meeting
10. Tigris Pharmaceuticals Presents Results of Breast Cancer Research at AACR Annual Meeting
11. Peregrine Pharmaceuticals Reports Positive Data in Second Phase II Bavituximab Breast Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... 2010 SynCo Bio Partners today,announced an ... recent initiation of a Phase 1 clinical trial in ... VRS-859. This news,comes less than 12 months since the ... product VRS-859 (exenatide-XTEN). , ... ...
(Date:7/29/2010)... , July 29 Isis Pharmaceuticals, Inc. (Nasdaq: ... $5 million milestone payment from GlaxoSmithKline (NYSE: GSK ... drug to treat an undisclosed rare and serious disease.  Isis will ... has the option to license it.   , ... "We are pleased to have ...
(Date:7/28/2010)... Bioengineers at the University of California, San Diego and ... wireless telemetry system that continuously monitors tissue glucose and ... published in the July 28, 2010 issue of the ... of this glucose-sensing device as an implant in animals ... FDA approval, the device may be useful to people ...
(Date:7/28/2010)... Burrill & Company, a San Francisco -based global leader in ... and Media, is pleased to announce that Shawn Cross ... immediately. , , , ... Cross will lead the Merchant Banking Group,s strategic growth plan, which ... needs of its clients at various stages in their growth. These ...
Breaking Biology Technology:SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials 2SynCo Bio Partners and Versartis Expand Collaboration as Lead Product Enters into Clinical Trials 3Isis Earns $5 Million Milestone Payment From GSK for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease 2Isis Earns $5 Million Milestone Payment From GSK for Designation of a Development Candidate to Treat an Undisclosed Rare and Serious Disease 3Implanted glucose sensor works for more than 1 year 2Implanted glucose sensor works for more than 1 year 3Implanted glucose sensor works for more than 1 year 4Shawn Cross Appointed CEO of Burrill Merchant Banking Group 2Shawn Cross Appointed CEO of Burrill Merchant Banking Group 3
... at an annual clip of 16 percent the past two ... historically known for beer, brats, and milk, says Gale Davy, ... State Capitol in Madison. , ,"Can you think of ... is the executive director of the Wisconsin Association for ...
... a Wisconsin company specializing in functional Magnetic Resonance Imaging ... and Drug Administration (FDA) issued a Special 510(k) approval ... MindState fDAD had previously received clearance in February 2005 ... allows Neurognostics to enhance fDAD by providing a library ...
... DirectorConnector , that connects businesses and non-profit organizations ... users, according to the two firms that started it ... LLP and the accounting firm of ... organizations in need of specially-skilled board members with qualified ...
Other Biology Technology:Bioscience beats beer 2
(Date:7/29/2010)... 2010): Today, the Association for Molecular Pathology (AMP) submitted ... made by the National Institutes of Health (NIH) for ... survey of its membership to formulate a comprehensive response ... respondents working in a clinical laboratory setting, AMP is ... to the GTR, including insight to the community,s concerns ...
(Date:7/29/2010)... (July 29, 2010) While pundits write obituaries for ... are already being felt across the world. We are ... managers have never before seen. , We need ... In that effort, Island Press and EcoAdapt are proud ... Knowledge Exchange (CAKE) at www.cakex.org . It is ...
(Date:7/29/2010)... PHILADELPHIAIn 1824, three years before he began to publish ... John James Audubon (1785-1851), the eminent artist of American ... grouse for use in the design for a New ... and the resulting engraved paper money in two separate ... locate or identify such an illustration., Now, after a ...
Breaking Biology News(10 mins):AMP responds to Genetic Test Registry request for information 2CAKE offers way forward for climate change adaptation 2Discovered: Audubon's first engraving of a bird 2EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean in Place Application 14057 1EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean in Place Application 14057 2EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean in Place Application 14057 3EAU Completes Approval Process for Electrolyzed Water as Sanitation Process for Industrial Clean in Place Application 14057 4Safe Routes to School Challenges Connecticut Students to Walk It and Bike It to School 57184 1Safe Routes to School Challenges Connecticut Students to Walk It and Bike It to School 57184 2Accuray Announces Additions to Board of Directors 57179 1Accuray Announces Additions to Board of Directors 57179 2Accuray Announces Additions to Board of Directors 57179 3
... Weapons Defense: Infectious Disease and Counterbioterrorism, deals with ... Press, this text is also available in e-Book. ... Army Medical Research Institute of Infectious Diseases (USAMRIID), ... 624-page, hardcover text edited by Luther E. Lindler, ...
... gene they suspect plays an important role in triggering ... century-and-a-half ago. , And the pathogen that contains this ... the modern world?on the order of billions of dollars ... Avr3a, in a study that appears online in the ...
... are in the laboratory. But those few plants are getting ... , The sugar beet industry moved out of Texas in ... But the growing research program within Texas Agricultural Experiment Station's ... said Dr. Charlie Rush, professor and director of the plant ...
Other Biology News:Researchers find gene that may be at root of potato blight 2Researchers find gene that may be at root of potato blight 3Sugar beet virus mutation requires Texas touch 2
... Clone/PAD: ZMD.478. Immunogen: Synthetic ... of the humanmouse and bovine Math-2. ... protein. Reactivity: Human Rat (positive ... rat B28 cell lysates and rat ...
...
solute carrier family 25, member 13 (citrin)...
Request Info...
Biology Products: